Eli O Meltzer: Influence Statistics

Eli O Meltzer

Eli O Meltzer

Allergy Allergy and Asthma Medical Group and Research Center San Diego California USA. | Allergy and Asthma Medical Group and Research Center, University of California School ...


Download all Influence Scores

Eli O Meltzer: Expert Impact

Concepts for which Eli O Meltzer has direct influence: Allergic rhinitis , Seasonal allergic rhinitis , Fluticasone propionate , Perennial rhinitis , United states , Nasal congestion , Seasonal allergic .

Eli O Meltzer: KOL impact

Concepts related to the work of other authors for which for which Eli O Meltzer has influence: Allergic rhinitis , Chronic rhinosinusitis , Nasal polyps , Fluticasone propionate , Asthma control , Quality life , Inhaled corticosteroids .

KOL Resume for Eli O Meltzer

Year
2021

Allergy Allergy and Asthma Medical Group and Research Center San Diego California USA.

Department of Pediatrics, University of California, San Diego, Calif. Electronic address:

2020

Allergy and Asthma Medical Group and Research Center, San Diego, Calif

2019

Allergy & Asthma Medical Group & Research Center, San Diego, CA, USA.

University of California, San Diego, La Jolla, CA, USA

2018

Allergy and Asthma Medical Group and Research Center, San Diego, Calif.

Department of Pediatrics, University of California San Diego School of Medicine, San Diego, CA, USA

2017

Clinical Professor of Pediatrics, Division of Allergy and Immunology, University of California, San Diego, CA, USA.

2016

Allergy & Asthma Medical Group & Research Center, San Diego, Calif

2015

Allergy and Asthma Medical Group & Research Center, San Diego, CA

2014

Allergy and Asthma Medical Group and Research Center, San Diego, California, USA.

2013

Allergy & Asthma Medical Group & Research Center, San Diego, California

2012

Allergy & Asthma Medical Group & Research Center, San Diego, CA

2011

Allergy and Asthma Medical Group and Research Center, San Diego, California, and

2010

Allergy and Asthma Medical Group and Research Center and University of California, San Diego, California

2009

Allergy & Asthma Medical Group & Research Center, University of California, San Diego, CA

2008

Allergy and Asthma Research Group and Medical Center, San Diego, CA, USA

University of California at San Diego and Asthma Medical Group and Research Center, San Diego, CA

2007

University of California at San Diego, Allergy and Asthma Medical Group and Research Center, San Diego, California, and

2006

Allergy and Asthma Medical Group and Research Center, San Diego, California 92123, USA.

2005

Allergy and Asthma Medical Group and Research Centre, San Diego

2004

Allergy & Asthma Medical Group & Research Center, San Diego, California.

2003

From athe Department of Pediatric Pneumology and Immunology, University Children's Hospital, Berlin; bthe Allergy and Asthma Medical Group and Research Center, San Diego; cthe National Allergy, Asthma and Urticaria Centers, Charleston; dthe Department of Clinical Immunology and Allergy, Medical University, Lodz; eAventis, Paris; fthe Department of Pediatrics, Karolinska Institutet, Stockholm; gthe Groupe Hospitalier Necker-Enfants Malades, Paris; hGhent University, Ghent; ithe Department of Allergology and Clinical Immunology, Hospital Dona Estefânia, Lisbon; jthe Division of Immunology and Respiratory Medicine, Hospital Infantil de Córdoba, Córdoba; kthe Allergology Diagnostic and Clinical Research Unit, University of Cape Town, Mowbray; and lthe Department of Pediatrics and Child Health, University of Manitoba, Winnipeg

Allergy & Asthma Medical Group and Research Center, A.P.C., San Diego, CA

Hamilton, Ontario, Canada, Newtown, Pa, and San Diego, Calif

2002

Allergy & Asthma Medical Group & Research Center, APC, San Diego, California.

2001

Allergy and Asthma Medical Group and Research Center, San Diego, CA.

Boston, Mass, and San Diego, Calif

2000

San Diego, San Jose, and Huntington Beach, Calif, and Rahway, NJ

1999

Allergy and Asthma Medical Group & Research Center, San Diego, California

San Diego, Mission Viejo, and Orange, Calif, Atlanta, Ga, Salt Lake City, Utah, Forked River and Kenilworth, NJ, Charleston, SC, Tucson, Ariz, New Braunfels, San Antonio, and Dallas, Tex, Easton, Pittsburgh, and Philadelphia, Pa, Ocala, Fla, and Rolla, Mo

1998

San Diego, Calif., and Kenilworth, N.J

This study was supported by Astra USA, Inc

Prominent publications by Eli O Meltzer

KOL-Index: 19140 . BACKGROUND: Cetirizine, a new once-daily highly specific H1-antagonist, has been shown in conventional studies to be efficacious in the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria. OBJECTIVE: The efficacy, duration and onset of action, and safety of cetirizine, 10 mg once daily, was compared with that of loratadine, 10 mg once daily, and placebo ...
Known for Seasonal Allergic Rhinitis | Cetirizine Loratadine | Placebo Period | Onset Action
KOL-Index: 19021 . BACKGROUND: In patients with severe asthma, tiotropium improves lung function and exacerbation risk when added to high-dose inhaled corticosteroids plus long-acting β2 agonists. We aimed to assess the safety and efficacy of tiotropium in patients with moderate asthma who were symptomatic despite treatment with medium-dose inhaled corticosteroids. METHODS: We did two 24-week, replicate, ...
Known for Inhaled Corticosteroids | Tiotropium Patients | Symptomatic Asthma | Μg Placebo
KOL-Index: 18589 . BACKGROUND: In fall 2004, the first Azelastine Cetirizine Trial demonstrated statistically significant improvements in the total nasal symptom score (TNSS) and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores with the use of azelastine nasal spray vs oral cetirizine in patients with seasonal allergic rhinitis (SAR). OBJECTIVE: To compare the effects of azelastine nasal spray ...
Known for Azelastine Nasal Spray | Seasonal Allergic Rhinitis | Intranasal Administration | Patients Sar
KOL-Index: 16042 . BACKGROUND: Fexofenadine HCl (Allegra, Telfast) is approved in the US for twice-daily dosing for treatment of seasonal allergic rhinitis. OBJECTIVE: To determine the effect of once-daily fexofenadine HCl on patient-reported quality of life and impairment at work, in the classroom, and in daily activities due to seasonal allergic rhinitis symptoms. METHODS: This placebo-controlled, ...
Known for Fexofenadine Hcl | Seasonal Allergic | Activity Impairment | Daily Activities
KOL-Index: 15664 . Many patients with allergic rhinitis (AR) have uncontrolled symptoms despite available treatment options. This study was designed to evaluate the efficacy and safety of MP29-02 (a novel intranasal formulation of fluticasone propionate [FP] and azelastine [AZ] hydrochloride), compared with monotherapy with FP, AZ, and placebo sprays for the treatment of seasonal allergic rhinitis (SAR). ...
Known for Fluticasone Propionate | Intranasal Formulation | Seasonal Allergic Rhinitis | Azelastine Hydrochloride
KOL-Index: 15213 . Although the annual prevalence of physician-diagnosed hay fever has been previously reported, the prevalence of allergic rhinitis symptoms in the United States is uncertain. The purpose of this study was to estimate the prevalence of allergic rhinitis symptoms in the United States. A self-administered 10-item screening questionnaire regarding nasal symptoms was sent to representative ...
Known for United States | Nasal Symptoms | Perennial Rhinitis | America Survey
KOL-Index: 14614 . Ipratropium bromide is an anticholinergic agent with topical activity that has been studied as a freon-propelled aerosol spray for therapy of nonallergic rhinitis. This is the first report of its use both as an aqueous nasal spray and in perennial allergic rhinitis. In this study 123 patients who had symptoms of perennial allergic rhinitis were randomized to receive ipratropium bromide 21 ...
Known for Ipratropium Bromide | Nasal Spray | Perennial Allergic | 42 Micrograms
KOL-Index: 14338 . Seasonal allergic rhinitis (SAR) treatment should reduce symptoms and help patients resume normal function. This study was performed to determine the effect of olopatadine (Olo) nasal spray on symptoms, quality of life (QoL), work, and activities of SAR patients. A pooled analysis was conducted of two Institutional Review Board-approved, randomized, double-blind clinical trials that ...
Known for Comprehensive Report | Quality Life | 06 Olo | Allergic Rhinitis
KOL-Index: 14254 . Rhinitis is a common chronic condition that has been shown in observational and interventional studies to have a substantial impact on the sufferer. This study was performed to describe the impact of symptoms of allergic rhinitis (AR) on sleep, quality of life, and productivity in a U.S. population. A cohort of AR sufferers and non-AR sufferers was assembled by screening a representative ...
Known for United States | Quality Life | Nasal Symptoms | Perennial Rhinitis
KOL-Index: 14219 . BACKGROUND: A nasal spray containing the antiallergy agent olopatadine hydrochloride is being developed for the treatment of seasonal allergic rhinitis (SAR). OBJECTIVE: To evaluate the safety and efficacy of 2 concentrations of olopatadine nasal spray vs placebo in patients with SAR. METHODS: This was a multicenter, randomized, double-blind, placebo-controlled study. After a 3- to 21-day ...
Known for Nasal Spray | Seasonal Allergic Rhinitis | Olopatadine Hydrochloride | Patients Sar
KOL-Index: 14103 . BACKGROUND: Comparative studies with topical corticosteroids and antihistamines for treatment of allergic rhinitis have not always demonstrated clear distinctions between the two on the basis of therapeutic efficacy. OBJECTIVE: This study was designed to compare the efficacy and tolerability of fluticasone propionate aqueous nasal spray with those of terfenadine in the treatment of ...
Known for Fluticasone Propionate | Seasonal Allergic Rhinitis | Aqueous Nasal Spray | 4 Weeks
KOL-Index: 13583 . BACKGROUND: Product attributes influence patient preference for intranasal corticosteroid therapy in allergic rhinitis (AR). OBJECTIVE: The aim of the study was to compare the product sensory attributes and patient preferences of fluticasone furoate (FF) and fluticasone propionate (FP) nasal sprays in patients with symptomatic perennial and/or seasonal AR. METHODS: This randomized, ...
Known for Allergic Rhinitis | Fluticasone Furoate | Sensory Attributes | Nasal Spray
KOL-Index: 13314 . BACKGROUND: The efficacy and safety of mometasone furoate aqueous nasal spray (MFNS; Nasonex) 200 microg once daily for the treatment and prophylaxis of seasonal allergic rhinitis (SAR) and treatment of perennial rhinitis have been demonstrated in adults. However, the dose response of MFNS in pediatric patients has not yet been characterized. OBJECTIVE: This study was conducted to ...
Known for Seasonal Allergic Rhinitis | Mfns Treatment | Mometasone Furoate | Nasal Spray
KOL-Index: 13282 . Quality of life, when referring to an individual's health, is called health-related quality of life (HRQL). HRQL focuses on patients' perceptions of their disease and measures impairments that have significant impact on the patient. Similar symptoms may vary in their effect on different individuals; the goal of therapy should be to reduce impairments that patients consider important. HRQL ...
Known for Life Hrql | Allergic Rhinitis | Specific Questionnaires | Disease Children

Key People For Allergic Rhinitis

Top KOLs in the world
#1
JeanClaude Bousquet
allergic rhinitis asthma control chronic respiratory diseases
#2
Giorgio Walter Canonica
allergic rhinitis severe asthma sublingual immunotherapy
#3
Eli O Meltzer
allergic rhinitis fluticasone propionate united states
#4
Paul B Van Cauwenberge
allergic rhinitis nasal polyps chronic rhinosinusitis
#5
Claus Bachert
nasal polyps chronic rhinosinusitis allergic rhinitis
#6
Alkis G Togias
allergic rhinitis peanut allergy infectious diseases

Allergy Allergy and Asthma Medical Group and Research Center San Diego California USA. | Allergy and Asthma Medical Group and Research Center, University of California School of Medicine, San Diego, CA, USA. | Division of Allergy and Immunology, Depa